Dr. Joyce Teng, MD

NPI: 1801850854
Total Payments
$115,109
2024 Payments
$32,320
Companies
21
Transactions
123

Payment Breakdown by Category

Consulting$70,509 (61.3%)
Other$18,160 (15.8%)
Travel$14,777 (12.8%)
Research$8,101 (7.0%)
Food & Beverage$3,542 (3.1%)
Education$21.19 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $70,509 29 61.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $16,760 5 14.6%
Travel and Lodging $14,777 20 12.8%
Unspecified $8,101 19 7.0%
Food and Beverage $3,542 47 3.1%
Honoraria $1,400 1 1.2%
Education $21.19 2 0.0%

Payments by Type

General
$107,008
104 transactions
Research
$8,101
19 transactions

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $20,657 18 $0 (2024)
Amryt Pharma Holdings Ltd $16,915 7 $0 (2023)
PFIZER INC. $15,996 17 $0 (2024)
Pierre Fabre Pharmaceuticals, Inc. $12,593 9 $0 (2024)
MITSUBISHI TANABE PHARMA AMERICA, INC. $10,710 5 $0 (2024)
LEO Pharma AS $6,208 14 $0 (2020)
NOBELPHARMA AMERICA, LLC $4,562 5 $0 (2023)
Novartis Pharma AG $4,000 1 $0 (2024)
Ipsen Biopharmaceuticals, Inc $3,885 2 $0 (2024)
Regeneron Pharmaceuticals, Inc. $3,750 2 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $32,320 29 MITSUBISHI TANABE PHARMA AMERICA, INC. ($8,750)
2023 $9,442 11 NOBELPHARMA AMERICA, LLC ($4,562)
2022 $13,644 10 Amryt Pharma Holdings Ltd ($8,878)
2021 $18,760 7 Amryt Pharma Holdings Ltd ($7,930)
2020 $10,731 7 PFIZER INC. ($4,736)
2019 $4,892 13 LEO Pharma AS ($4,442)
2018 $15,237 26 Pierre Fabre Pharmaceuticals, Inc. ($6,697)
2017 $10,084 20 PFIZER INC. ($6,930)

All Payment Transactions

123 individual payment records from CMS Open Payments — Page 5 of 5

Date Company Product Nature Form Amount Type
03/16/2018 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $61.67 General
02/28/2018 Pierre Fabre Pharmaceuticals, Inc. Travel and Lodging Cash or cash equivalent $6,697.46 General
02/16/2018 Celgene Corporation Food and Beverage In-kind items and services $55.80 General
12/12/2017 Dr.Reddy's Laboratories,Inc. Consulting Fee Cash or cash equivalent $642.00 General
11/30/2017 PFIZER INC. EUCRISA (Drug) Travel and Lodging In-kind items and services $141.60 General
Category: DERMATOLOGY
11/16/2017 PFIZER INC. EUCRISA (Drug) Consulting Fee Cash or cash equivalent $5,675.00 General
Category: DERMATOLOGY
10/07/2017 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $442.55 General
Category: DERMATOLOGY
10/07/2017 PFIZER INC. EUCRISA (Drug) Travel and Lodging In-kind items and services $312.06 General
Category: DERMATOLOGY
10/07/2017 PFIZER INC. EUCRISA (Drug) Travel and Lodging In-kind items and services $199.57 General
Category: DERMATOLOGY
10/07/2017 PFIZER INC. EUCRISA (Drug) Travel and Lodging In-kind items and services $127.72 General
Category: DERMATOLOGY
07/28/2017 PFIZER INC. Food and Beverage In-kind items and services $15.22 General
06/19/2017 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $6.00 General
Category: DERMATOLOGY
04/28/2017 PFIZER INC. EUCRISA (Drug) Food and Beverage In-kind items and services $9.88 General
Category: DERMATOLOGY
04/27/2017 Dr.Reddy's Laboratories,Inc. Consulting Fee Cash or cash equivalent $367.00 General
03/06/2017 Eli Lilly and Company TALTZ (Drug) Travel and Lodging Cash or cash equivalent $35.99 General
Category: Immunology
03/06/2017 Eli Lilly and Company Food and Beverage Cash or cash equivalent $28.35 General
03/05/2017 Theravance Biopharma Inc. Consulting Fee Cash or cash equivalent $500.00 General
03/03/2017 Eli Lilly and Company TALTZ (Drug) In-kind items and services $433.63 Research
Study: MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY, AND EFFICACY OF IXEKIZUMAB IN PATIENTS FROM 6 TO LESS THAN 18 YEARS OF AGE WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS • Category: Immunology
03/03/2017 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $43.08 General
Category: Dermatology
02/11/2017 Eli Lilly and Company Food and Beverage In-kind items and services $330.00 General
02/11/2017 Eli Lilly and Company Travel and Lodging In-kind items and services $223.20 General
02/11/2017 Eli Lilly and Company Travel and Lodging In-kind items and services $212.63 General
02/10/2017 Eli Lilly and Company Travel and Lodging In-kind items and services $338.09 General

Research Studies & Clinical Trials

Study Name Company Amount Records
ABROCITINIB CLINICAL PUBLICATION PROGRAM PFIZER INC. $4,470 3
TRALOKINUMAB VACCINE RESPONSE TIME LEO Pharma AS $1,535 5
A Phase 3, Open-label, Efficacy-Assessor-Blinded Study, Comparing the Safety and Efficacy of Upadacitinib to Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis ABBVIE INC. $1,421 9
MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY, AND EFFICACY OF IXEKIZUMAB IN PATIENTS FROM 6 TO LESS THAN 18 YEARS OF AGE WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS Eli Lilly and Company $674.89 2

About Dr. Joyce Teng, MD

Dr. Joyce Teng, MD is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801850854.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joyce Teng, MD has received a total of $115,109 in payments from pharmaceutical and medical device companies, with $32,320 received in 2024. These payments were reported across 123 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($70,509).

Practice Information

  • Specialty Dermatology
  • Other Specialties Pediatric Dermatology, Pediatric Dermatology
  • Location Palo Alto, CA
  • Active Since 04/14/2006
  • Last Updated 04/16/2024
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1801850854

Products in Payments

  • VIJOICE (Drug) $10,495
  • EUCRISA (Drug) $6,920
  • HEMANGEOL (Drug) $5,750
  • HYFTOR (Drug) $4,562
  • ENSTILAR (Drug) $4,506
  • PIQRAY (Drug) $4,000
  • DUPIXENT (Biological) $3,854
  • FILSUVEZ (Drug) $3,565
  • Orladeyo (Drug) $1,650
  • Tremfya (Drug) $1,556
  • RINVOQ (Biological) $1,299
  • TALTZ (Drug) $710.88
  • LITFULO (Drug) $103.06
  • CIBINQO (Drug) $86.99
  • Otezla (Drug) $76.01
  • DUPIXENT DUPILUMAB INJECTION (Biological) $29.80

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Palo Alto